Literature DB >> 34711572

Prescribing the oral contraceptive pill: key considerations for primary care physicians.

Rima Chakrabarti1, Rini Chakrabarti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34711572      PMCID： PMC8544156          DOI： 10.3399/bjgp21X717653

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  5 in total

Review 1.  Pharmacology of estrogens and progestogens: influence of different routes of administration.

Authors:  H Kuhl
Journal:  Climacteric       Date:  2005-08       Impact factor: 3.005

2.  Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.

Authors:  Qi Yu; Yingfang Zhou; Larisa Suturina; Unnop Jaisamrarn; Dongmei Lu; Susanne Parke
Journal:  J Womens Health (Larchmt)       Date:  2018-06-29       Impact factor: 2.681

Review 3.  20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

Authors:  Maria F Gallo; Kavita Nanda; David A Grimes; Laureen M Lopez; Kenneth F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2013-08-01

4.  Effects of continuous versus cyclical oral contraception: a randomized controlled trial.

Authors:  Richard S Legro; Jaimey G Pauli; Allen R Kunselman; Juliana W Meadows; James S Kesner; Richard J Zaino; Laurence M Demers; Carol L Gnatuk; William C Dodson
Journal:  J Clin Endocrinol Metab       Date:  2007-12-04       Impact factor: 5.958

5.  Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning.

Authors:  Mahnaz Shahnazi; Somaye Bayatipayan; Azizeh Farshbaf Khalili; Fatemeh Ranjbar Kochaksaraei; Mohammad Asghari Jafarabadi; Kamala Gaza Banoi; Jila Nahaee
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.